CBDNewsBreaks Archive - Page 34 of 278

ThursdayApr 15, 2021 11:42 am

CBDNewsBreaks – XPhyto Therapeutics Corp.’s (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) ‘Covid-ID Lab’ Combines Speed of Rapid Screening with Accuracy of PCR Diagnostic

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience technology accelerator, is set to launch a solution for improving detection of the virus responsible for the worldwide pandemic. The company recently announced European regulatory approval of its point-of-care SARS-CoV-2 (COVID-19) RT-PCR test system. Known as “Covid-ID Lab,” the system is a commercial in-vitro diagnostic device (CE-IVD) designed to help industry professionals and government agencies screen for the virus. XPhyto’s exclusive German diagnostics partner, 3a-diagnostics GmbH, developed Covid-ID Lab to provide rapid, accurate and portable testing capabilities, granting it marketability as a product with increased convenience and decreased operating costs.…

ThursdayApr 15, 2021 11:04 am

CBDNewsBreaks – Hero Technologies Inc. (HENC) Retains Patent Attorney to Solidify Cannabis Intellectual Property Rights

Hero Technologies (OTC: HENC), a cannabis company focused on a vertically integrated strategy, today announced that it has retained a patent attorney to help protect and monetize the intellectual property of its subsidiary, BlackBox Systems and Technologies LLC. BlackBox has developed a proprietary cannabis growing system based on aeroponic cultivation technology. The system creates ideal cannabis growing conditions, which enhance photosynthesis, produce large plant flowers and optimize harvests. The company's new intellectual property attorney is Alan M. Weisberg, Esq., a partner of Christopher & Weisberg, P.A. Weisberg is a registered patent attorney with a "preeminent" peer rating and more than…

FridayApr 09, 2021 1:21 pm

CBDNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Targets Investments that Complement, Further Business Goals

Pac Roots (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM), an innovative genetics-based cannabis company located in Canada, recently acquired a large tract of land (250 acres) in one of Canada’s most productive and intensively farmed areas. “The company is also in the process of completing its 20,000-square-foot cultivation facility in Lake County, B.C., that will allow it to cycle through an elite line of high-grade cultivars across roughly 7,600 square feet of cultivation space,” reads an article discussing Pac Roots’ recent moves. The land and cultivation facility are part of a growing list of investments, given that the company recently completed…

ThursdayApr 08, 2021 1:25 pm

CBDNewsBreaks – Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) Closes on Majority Ownership of Plant-Based CBD Skincare Brand

Golden Leaf Holdings (CSE: GLH) (OTCQB: GLDFF), a premier, consumer-driven cannabis company specializing in retail, production, processing, wholesale, and distribution, has closed on the purchase of its majority ownership in Fifth & Root Inc., a California-based, nationally recognized CBD skin-care brand. Fifth & Root noted that it hopes the move will allow the company to provide innovative CBD products nationwide through the largest and best beauty retail partners in the country. The purchase agreement noted that GLDFF will pay total consideration of up to $1,687,500 for 80% ownership of Fifth & Root. The consideration will consist of $250,000 cash payment…

ThursdayApr 08, 2021 10:11 am

CBDNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Releases Q4, FY 2020 Audited Financial Report

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a cannabis and hemp-branded products company in the United States, has released audited financial and operational results for fourth-quarter and fiscal year periods ending Dec. 31, 2020. Financial highlights from the report include an increase in gross profits of 104% in 2020, totaling $5.6 million in 2020 compared to $2.8 million in 2019; cash balance of $11.6 million; an increase in net revenues of 15% from 2019, with 2020 totals reaching $15.9 million; and a 67% improvement in operating costs. The company also noted several key new product launches throughout the year, including the…

WednesdayApr 07, 2021 9:31 am

CBDNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) Launches CBD Product Line in Asia Through Tmall

HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, has received conditional approval to offer its proprietary CBD products on Tmall, the world’s largest cross-border online marketplace. This news follows the company’s recent announcement that its Probulin Probiotics would also be available on Alibaba Group Holding’s Tmall Global (“Tmall”). The third most-visited website in the world, Tmall represents more than 750 million potential new consumers living across mainland China, Hong Kong, Macau and Taiwan. The announcement noted that the site provides unique opportunities for HempFusion to raise…

MondayApr 05, 2021 2:22 pm

CBDNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) Releases Operational Update, FY 2020 Results

HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, has released both an operational update and the filing of its annual and fourth-quarter financial results for the fiscal year ended December 31, 2020. Company highlights include being ranked no. 2 in Brightfield Group’s most recent survey in the CBD Brand Awareness (U.S.) category, as well as SPINS naming its proprietary Probulin Probiotics product fastest-growing probiotic brand in 2020 out of the top 10 in the country. Other highlights included being the no. 2 CBD holding in AdvisorShares…

FridayMar 26, 2021 1:58 pm

CBDNewsBreaks – RYAH Group Inc. Holds Key Distinction in Telehealth Era

RYAH Group, a company developing proprietary technology supporting a data-driven approach to health care, appears ready to respond to strict data security requirements. This is an important distinction in an era where the use of telehealth solutions is exploding while securing the integrity of patient information remains critical. The Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) is U.S. legislation surrounding requirements for medical providers to integrate privacy and security provisions to safeguard their patient’s medical data. Although HIPAA guidelines are temporarily relaxed during the pandemic, this flexibility is not likely to remain and it is. Therefore, it is…

ThursdayMar 25, 2021 1:14 pm

CBDNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) Announces Completion of Pilot Trial, Releases White Paper

HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, has completed a pilot study assessing the effect of its HempFusion formulation CBD Capsules(R) (HempFusion 20mg CBD capsules with botanical terpenes) as it relates to a combination of anti-inflammatories in lowering the results of the chronic inflammation test. The study was conducted in collaboration with Kansas-based Inflammatory Markers Laboratory (“IML”). In addition, the company also released a white paper titled, “Oral Formulation May Modulate Thromboxane Production.” The white paper was s co-authored by IML director Gordon Ens and…

WednesdayMar 24, 2021 2:09 pm

CBDNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Working to Expand Test Portfolio

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), which recently received European approval for its COVID-19 rapid and portable test system, has set out to increase its portfolio of tests for different diseases to help fight the current and potential pandemics. XPhyto has partnered with Germany’s 3a-diagnostics GmbH for this, according to an article on the company’s recent announcements. “The company is also working with 3a to develop a portfolio of oral biosensor screening tests that detect bacterial and viral infectious diseases ranging from influenza A to group A strep, as well as focusing on other potential pandemic biosensor tech…

News and publishing service for CBD related companies

Contact us: 512.354.7000

CannabisNewsBreaks